Zepbound Updates: Me, and In the News

I’ve now been on Zepbound for 70 weeks, and I was just looking over my notes on my progress over that time.1 For the first 35 weeks, I was losing about a pound a week and without thinking about it much. I didn’t exercise or diet more than usual (though I did and still do exercise and watch what I eat); I just wasn’t as hungry and so I didn’t eat as much.

Since week 35 (which was September 2024), I’ve lost just shy of eight more pounds– about 3 more pounds since the last time I wrote here about this— for a total of around 42-43 pounds. So on the one hand, I haven’t completely plateaued in my weight loss progress, and at least I am still heading in the right direction. Plus even with the stall, I’m still a lot less fat (and more healthy) than I was before I lost the weight– and at least I haven’t gained it back (yet). On the other hand, I ain’t going to get to my goal, which means losing about another 17-20 pounds, with Zepbound alone.

Obviously, that means I need to start doing something closer to acutally dieting and exercising more– or at least I need to shake up the routine/rut, and I’ll be doing that for the next month. Annette and I are going on a month long trip through Europe starting next week as part of a celebration of our 31st wedding anniversary, a trip that was delayed by a year because we decided to buy a new house. I won’t be dieting, and because it will not be easy to refrigerate Zepbound as we go from place to place, I’ll have to skip a week of dosing at the end of the trip.2 Still, I’m not worried because on trips like this that involve a lot of walking around, I almost never gain weight.

But enough about me (or just me). There’s been some interesting Zepbound news in the last couple of months. A few highlights:

  • Access to Zepbound and similar weight loss drugs remains a significant problem. There was an article about this in The New York Times back in December, and how several other state’s biggest insurers have cut back on coverage. My insurance still covers it, but they have added additional hoops I need to jump through for me to get the drugs.
  • One of the other ways that access has been reduced is new restrictions of compound pharmacy and other “knock-off” versions of these drugs. Basically, because these drugs are no longer in short supply from manufacturers, companies that make their own version of Zepbound (and there are a lot of companies like this) can no longer sell their own versions. The drug manufacturers and companies like Ro have been making deals to make the drugs a little less expensive, but they’re still expensive. I’m just happy that I don’t have to decide if it would be worth the $700 or so it would cost me a month out of pocket (and honestly, it might be).
  • Still, there’s a lot of optimism about the near future of these drugs. Eli Lilly Chief Scientific Officer Dan Skovronsky gave an interview on CNBC where he talked about a daily pill as effective as a weekly injection will be available soon (maybe by the end of the year), stronger versions of these drugs, and also using these drugs for lots of stuff besides weight loss specifically: heart disease, sleep apnea, and maybe other things like addiction. Sure, this guy is trying to sell Eli Lilly drugs, but there are a lot of articles out there reporting similar things.
  • Just a few days ago, there was this article in The New York Times, “Group Dining on Ozempic? It’s Complicated,” which is about the social etiquette of being on a GLP-1 drug and out to eat with others where you don’t eat that much. I am obviously not shy about the fact that I’m taking Zepbound, so when I’m eating with others at a restaurant or at a dinner party, I just tell people it’s the drugs. Annette and I went to a breakfast diner place in Detroit in April, and I ordered what turned out to be an enormous skillet of eggs, hash browns, sausage, and peppers and onions. It was delicious, but I could barely eat half. When the waitress came away to clear our plates, she seemed concerned that I might not have liked it. “No, it’s great– it’s just I’m taking one of those weight loss drugs and I can’t eat more.” “Oh yeah?” she said. “How’s it going? I have a cousin of mine who is on one of those things and has last 50 pounds.” So at least she understood.
  • And then there was the recent news that Weight Watchers (aka WW International) was going bankrupt largely as a result of people shifting to drug alternatives instead. I saw this op-ed in The New York Times on the mixed messages of Weight Watchers, “Weight Watchers Got One Thing Very Right” by Jennifer Weiner. On the one hand, Weiner points out a lot of the dieting culture promoted by Weight Watchers was harmful. A lot of mothers took their slightly overweight but still growing/developing daughters to Weight Watchers too early, and a lot of their customers never succeeded and yet kept coming back, “stuck in a cycle of loss, regain and shame that didn’t ultimately leave them any thinner, even as it fattened Weight Watchers’ coffers.” On the other hand, Weiner says Weight Watchers provided its customers– especially women– a sense of community at what were (pre-Covid, of course) regular meetings. They were safe “third spaces,” a gathering that was one of the “all-too-rare places in America where conservatives and progressives found themselves sitting side by side, commiserating about the same plateaus or the same frustrations or the same annoyance that the power that be had changed the point value of avocados, again.”

I’ve written about this before, but I actually was Weight Watchers member and attended meetings (with my wife) for about three years in I believe the early 2010s. The regular meeting we attended was similar to what Weiner describes. It was at a WW storefront center in a strip mall located right next to a Chinese restaurant. Whenever I went, I always peed right before weighing in, anxious to cut every possible ounce. Then there’d be a meeting that lasted anywhere from 30 to 45 minutes where people “shared,” and where the leader (in our case, a gay man named Robert) led us through some lesson, mostly built upon stories of his own weight loss he’d repeat over and over. I was not the only man to attend these meetings, but yes, mostly women. Annette and I attended regularly enough to know most of the other “regulars,” and to also spot folks who would show up once or twice and never again. I do not remember any discussions about exercise, or really any other weight loss advice that went beyond “eat less.” In those three years, my weight did not change, and I never felt the sense of belonging to a community. It felt pretty hopeless by the end. So yeah, I don’t feel too badly about the demise of WW.

  1. As part of my journaling practices, I write down my weight for the morning and I also have a part where I track my weight on the days where I take Zepbound. ↩︎
  2. Zepbound needs to be stored in the fridge, but it can be kept at room temperature for up to 21 days. So I’ll have to skip one dose in the last week we’re gone and then I’ll be able to return to normal when we get back. That’s a good thing because if I miss two weeks, I need to start over on Zepbound with the lowest dose, and as far as I can tell from my limited internet research, people who restart with Zepbound often don’t have the same level of success the second time around. ↩︎

Zepbound, One Year Later (and related thoughts)

My one year of Zepbound anniversary passed a couple of weeks ago without any real notice or celebration on my part. I started the drug on January 7, 2024. I‘ve blogged about my experiences on Zepbound a few times before in the last year, and so far, so good. Mostly.

The good news is I’ve lost about 40 pounds so far. My goal is to lose another 20 pounds, which, according to the problematic BMI scale, would just barely move me into the category of “overweight” from where I am now, which is “obese.” I know, I know, it probably doesn’t matter a whole lot if I manage to get my BMI from a 31 to a 29, but still, it’s a goal.

Anyway, I’m feeling pretty good. The last time I had blood work done as part of my yearly check-up was back in June and after I’d lost about 25 pounds. My various numbers had improved (I moved out of the “pre-diabetic” category, for example), so I’m assuming that all of that would be even better now. The main side effect I have from Zepbound are all “tummy issue” related, and I still do have a bit of that, especially for a day or two after I inject myself. But it’s still not a big deal. And the stuff I wrote about before is still true: it’s easier to exercise (though I haven’t been “running” as much lately, now that I think about it), I find myself eating healthier (I mean besides just eating less), I’m enjoying the fact that I have had to once again buy some new clothes that fit better, and so forth.

The bad news is I’ve only lost about 6 pounds since the beginning of October. I think there are two reasons for this. First, I think it’s fair to say my main remaining food weakness is sweet things. My cravings for fatty things like a Big Mac are way down, but I still like candy. So fall and winter were rough with all the leftover Halloween candy (especially since we literally only had 3 very small kids with their parents knocking on our door out here in the new house!), with pies and just excesses at Thanksgiving, cookies and cakes and stuff at Christmas, etc.

Second, I think I’ve reached the limits of the drug’s effectiveness alone. As I wrote about back in May (after I had lost about 20 pounds), the reason why Zepbound was working for me was I just wasn’t as hungry, so I didn’t eat much between meals and when I did sit down for dinner or lunch, I ate less. So it didn’t feel like I was trying at all.

But at this point, if I’m going to lose another 20 pounds, I am going to need to try. For me, “trying” means being more in an “I’m on a diet” mindset in the sense cutting back even more on calories, eating even better, doing more at the gym, all that kind of stuff. I think the Zepbound helps with that too. Besides quieting the so-called “food noise,” it also helps me to better recognize when I’m eating just to eat, versus eating when I’m actually hungry. One of the ways it does this is if I do find myself hungry nowadays, it’s almost certainly because I actually do need to eat something.

But enough about only me. What else is in the news about GLP- 1 drugs and Zepbound and the like? Here’s a few articles that struck me as interesting in recent months.

  • From something called The List comes “Elon Musk’s Holiday X Post Surely Got Under RFK Jr.s Skin (& Caused Trouble for Trump.)” Apparently, Elon has lost a bunch of weight from these drugs too. Among other things, Musk posted on X “Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors super low cost to the public. Nothing else is even close.”

    RFK Jr. is no fan of these drugs at all, and he’s quoted in this article (from other sources) saying “If we just gave good food, three meals a day, to every man, woman and child in our country, we could solve the obesity and diabetes epidemic overnight.”

    Funny enough, I think both of these fascist meatbags full of shit are correct. As I’ll get to next, these drugs have all kinds of benefits, including a lot of things well beyond weight loss. The two main barriers for making them more available are the injectable format and the high costs. Also no question that Kennedy is right too: good food isn’t going to solve these problems “overnight,” but I get his point. But for me (and I’d bet 99% of GLP-1 users), it’s not an either/or thing– the drugs help me eat better.
  • There were several MSM articles about a study that was published in Nature Medicine called “Mapping the effectiveness and risks of GLP-1 receptor agonists.” That link to Nature Medicine only works at all if I access it through the EMU library, so your results will vary. Anyway, the study used the US Department of Veterans Affairs database to study hundreds of thousands of patients who had used these drugs, primarily for diabetes. As Time summed it up, patients taking “GLP-1 medications had a lower risk of a number of health conditions, including Alzheimer’s disease and dementia, addiction, seizures, blood-clotting problems, heart conditions, and infectious diseases, compared to people taking the other types of diabetes treatments. The people taking the GLP-1 drugs also had increased GI-related issues, low blood pressure, and arthritis, as well as certain kidney conditions and pancreatitis—most of which are already known side effects of the medications.”
  • I have a news alert for Zepbound, and I see a lot of articles like this one: “The Best Obesity Drugs Aren’t Even Here Yet,” from Gizmodo. Take that with a smaller piece of cake (if you will), but the success of Ozempic and other drugs like this have fueled a bit of a gold rush in research. Soon there are going to be versions of these drugs that are more effective, and, with any luck once they are available in pill form, versions that will be a lot cheaper.
  • And last, I guess Oprah got into a bit of trouble the other day. From Page Six, “Oprah Winfrey faces backlash for making bold claim about ‘thin people’ after taking weight-loss drug.” Read the whole thing, but I guess you can see the “bold claim” in this snippet on Instagram:

I mean, I am not in the business of defending Oprah, especially since she originally denied that she was taking these drugs to lose weight. And I’ve never been a skinny person, and of course people end up being skinny (or fat) for all kinds of different reasons. But I have had conversations similar to this with skinny (or not overweight at least) people, and I think what Oprah is saying here is right– at least for about half of the thinner/very in shape people I know well. One very skinny guy I know told me one time he has to remind himself to eat some days, and I assure that has never been a problem for me.

But I will say there is one other category of skinny/very fit people I have known over the years: the person who got a serious medical wake-up call. I’m talking about having a doctor say if you don’t make some seriously big changes in diet and exercise, you’re gonna die a lot sooner than you should. I think this category is much smaller than the category of “I never feel that hungry,” but I can see why these people might not like Oprah implying they don’t have will power or “work” at it.

The Year 2024 was A LOT

This past year was A LOT for me and the rest of my family. So so SO much happened, so much of it horrible and still difficult to comprehend, so much of it fantastic and beautiful. I suppose this “the worst of times/the best of times” sentiment is always kinda true, but I can’t think of another year where there was just so so much and in such extremes.

It’s been a lot. It’s been way too much for one year.

January

We were already well underway with one of the big ticket items of this year, which is building/buying/selling houses and moving for the first time in over 25 years.

On January 7, I started taking Zepbound, which is one of these weight loss drugs in the category of what everyone has heard of, Ozempic (though, as I wrote about during the year, it’s more complicated than that.)

Otherwise, it was mostly the start of the winter term with work (it was the semester of all freshman composition for me), weather, watching some cheesy movies here and there.

February

My niece Emily got married in a huge and very Catholic ceremony in Kansas City. This was the first of the nieces/nephews (or cousins or grandchildren, depending on your perspective) to get married, so a big deal for the Krauses. Remarkably, there were no hitches with the weather or anything else.

The idea of moving started to get a lot more real when we were able to do a walk-through of the house right after they did the inspection for stuff they need to do before they put up drywall.

Of course, we (mostly me) have been driving by the construction site since November to see the progress, but walking around in what would become (in the order of these pictures) the upstairs/Steve loft area, stairs descending in the living room/main room and kitchen area was pretty cool. The Zepbound adventures continued (I was down about 7 pounds by the end of the month) as did the all first year writing semester.

March

We started getting real about selling the old house and preparing the move to the new one, and because we lived in our previous house in Normal Park for 25 years, it was stressful. I mean, we had decades worth of stuff to sort through– pack, sell, toss– and there was all the decluttering and the nervousness of would it sell and would we get what we were asking and all that. It’s kind of funny because everyone we talked to about this stuff– including my parents and in-laws– had all moved at least once (and usually twice) in the 25 years we hadn’t thought of it at all.

It’s funny to think about too because Annette grew up as an Air Force brat and her father was in for over 20 years, meaning she moved more than a dozen times before she was 15. I didn’t move that much as a kid, but we did move a couple of times, and in college and through my MFA program, I moved almost every year. So we used to know how to move.

School continued, my adventures with Zepbound continued and I complained about Oprah, I kept messing around with AI, kept teaching, etc., and I turned 58, too.

April

April was the beginning of the “A LOT,” the far too much of the year. We had two open houses on the first Sunday of the month, and then on April 8, Annette and I cleared out to make room for potential buyers to come take a second look while we went to the eclipse. We met our friends Steve and Michelle and their daughter down in Whitehouse, Ohio (just outside of Toledo), which seemed like the easiest place to get to for the totality while avoiding bumper-to-bumper traffic into the “totality zone” in northern Ohio.

As I wrote on Instagram, being there for the totality was intense. I probably won’t be able to see another total eclipse in my lifetime; then again, a cruise in August 2027 in the Mediterranean is not impossible.

We had a second open house, which was nerve-wracking. Remember, we had not had anything to do with selling and buying a house in forever and everyone told us we’d get an offer immediately, so when that didn’t happen, we started contemplating scenarios about how we can swing paying for the new house without money from the sale of the old house and all of that. Well, another open house and we got an offer and everything worked out– eventually.

And the end of April was when Bill died, suddenly and just a few days after a group of us got together for dinner. That’s at the top of my list for of horrible and difficult to comprehend. It still doesn’t feel real to me, and I think about Bill almost every day.

May

MSU had a quite large memorial for Bill in early May we were able to attend– Will flew back too. There had to be at least 500 people at it, and it was as celebratory about a remarkable life as it could be. I wrote about some of this in early May here, though this is as much about my own thoughts of mortality than anything else. Like I said, this year has been a lot, and this was the horrible part.

And in mid-May, we closed on both houses and pretty much on the same day. We went to a Title office in Ann Arbor and met the guy who bought our house for the first time, and without going into a lot of details, I feel pretty confident that that he and his partner (who was there via Facetime) are a great fit, ready for the adventures and challenges of fixing up the place and making it their own. That was the selling part. The buying part of the new house we were able to do electronically, and weirdly and quite literally while we were running errands after the closing where we were selling, we received a number of emails to electronically sign some forms and boom, we bought the new house too.

It was and still is kind of bitter-sweet, leaving the old place and the old neighborhood. It was time to move on and the longer we are in the new place, the fewer regrets I have. Still, when you live someplace for 25 years, that place becomes more than just housing, and that is especially true when it is in such a great neighborhood. I still drive through the old neighborhood and the old house about once a week on my way to or from EMU.

Five months after starting Zepbound, I finally got to the full dose of the meds and I was down about 20 pounds.

June

A lot of the last part of May and the first part of June was a complete daze of moving. We decided that the way we’d move is to start taking stuff over a carload at a time (and I did most of the heavy lifting, mostly because Annette was teaching a summer class) and then hiring movers for the big stuff later. I remember talking with my father about this approach to moving, and his joke was it’s sort of like getting hit in the nuts fairly gently every day for a month, or getting hit once really hard. When we move again (no idea when that will be), I think the smarter move would be to do it all at once, but I don’t think there’s any escaping what Annette and I had erased from our memories after staying put so long: moving sucks.

Also in June: we celebrated our 30th wedding anniversary. Well, sort of. Before we started getting serious about buying a new house, the original plan was go go on a big European adventure that sort of retraced the trip we took for our honeymoon, but we decided to give each other a house instead. The 31sth wedding anniversary trip to Europe is coming this spring instead.

As part of the house closing deal, we were able to be in the old house through the first weekend in June and we had one last Normal Park hurrah by selling lots and lots of stuff in the annual neighborhood big yard sale event. I went once last time on June 10 to mow the lawn, double-check to make sure everything was cleaned up, and to do one last terror selfie.

July

The new house– the cost of it of course, but also just settling into it and all– meant we didn’t travel anyplace this summer in I don’t know how many years. I missed going up north, and we might not be able to do that again this coming year either. And we watched the shitshow that was the presidential election tick by. But there was golf, there was more AI stuff, hanging out with friends, going to art fairs in Plymouth and Ann Arbor, seeing movies and hanging out. Annette went to visit her side of things in late July, leaving me to fly solo for a few days, and her parents came back with her to stay in the new place for a while, our first house guests.

August

The in-laws visited, we went for a lovely little overnight stay in Detroit. played some golf, started getting ready for teaching, and I wrote a fair amount about AI here and in a Substack space I switched to in August. The switching back happened later. Started feeling optimistic about Kamala’s chances….Oh, and my son defended his dissertation and is now Dr. William Steven Wannamaker Krause (but still Will to me).

September

By September 5, when I wrote this post about both weight loss and Johann Hari’s book about Ozempic called Magic Pill, I was down about 35 pounds from Zepbound. The semester was underway with a lot of AI things in all three classes. There was a touch of Covid– Annette tested positive, I don’t think I ever did, but I felt not great. My parents visited in the end of September, and of course they too liked the new house.

October

The month started with a joint 60th birthday for Annette and our friend Steve Benninghoff– they both turned 60 a few months apart. It was the first big party we had here at the new house. During EMU’s new tradition of a “Fall break,” we went to New York City. We let up with Will and his girlfriend and went to the Natural History Museum (pretty cool), went with them to see the very funny and silly Oh, Mary! Annette and I also went to see the excellent play Stereophonic and met up with old friends Troy and Lisa, and also Annette at an old school Italian restaurant that apparently Frank Sinatra used to like a lot. Rachel and Colin came by for dinner when they were in town too. And of course school/work, too.

November

We started by going to see Steve Martin and Martin Short at the Fox Theater in Detroit— great and fun show. Then, of course, there was the fucking election, another bit of horrible for the year. More Substack writing about AI and just being busy with work– the travels and events of October really put me behind with school, and I felt like I spent the last 6 or so weeks of the semester just barely caught up on it all. Will and his girlfriend came out here before Thanksgiving and she flew back home to be with her family. Meanwhile we made our annual trip to Iowa for Thanksgiving/Christmas. A good time that featured some taco pizza the day after the turkey, and happily, very very little discussion of politics.

December

The semester ended more quickly than usual, just a week after Thanksgiving rather than two. I was pretty pleased with the way the semester turned out overall; I definitely learned a lot more about what to do (and not do) with AI in teaching, and I hope my students got something out if it all too.

I ended up switching back to blogging but not quite giving up on Substack, as I talked about in this post. One of my goals for winter 2025 is to start a more focused Substack newsletter on my next (and likely last) academic research project on the history of AI, Computer Aided Instruction, and early uses of wordpressors in writing pedagogy from the late 70s until the early 90s. Stay tuned for that.

Oh, and the niece I had who was the first of the cousins to get married? Also the first to have a baby in early December– thus the first great-grandchild in the family.

There was much baking (in November too), and some decorating and some foggy pictures of the woods. Will and his girlfriend returned (I think Will has been back here more in the last couple of months than he has been in quite a while) and we took a trip to the Detroit Institute of Art before they left to California to see her family. Will came back here, we made the annual trip to Naples, Florida to see the in-laws, and now here we are.

Like I said, it’s been a lot, and a whole lot of it is bad. I worry about Trump. I miss Bill terribly. He touched a lot of people in his life and so I know I’m not alone on that one.

But I’m also oddly hopeful for what’s to come next. The more we are in the new house, the more it is home. The Zepbound adventure continues (I’m down about 40 pounds from last January), I’m hopeful for Will as he starts a new gig as a post-doc researcher, I’m looking forward to the new term, and I’m looking forward to all that is coming in the new year.

Me and Johann Hari Swap Weight Loss Med Stories

Zepbound, Starting Month 9

I am beginning my ninth month on Zepbound, and so far, I’ve lost around 35 pounds, which averages out to about a pound a week. When I started Zepbound in January, I had a BMI that was just on the edge of “morbidly obese;” now I’m solidly “obese.” I can now run for a mile on the track at the gym without stopping (well, my “run” is more like a jog that isn’t walking, and I am often passed by taller people who are fast-walking), a goal I’ve been trying to reach for a long time. I went to my doctor for a physical in June, and learned my cholesterol (which has been under control for a while with a statin) was even lower, and, more importantly, my AIC numbers went from pre-diabetic to normal. A couple of weeks ago, I went through my closet and drawers. I set aside almost all of my pants and jeans and went shopping for things that actually fit.

So, so far, so good. As I described in a bit more detail in my previous Zepbound post, I still have nausea and other tummy-trouble side effects for a day or two after I inject, and it has changed in subtle and not subtle ways the way I think about food. I’m also feeling like after nine months, I need to be a more conscious participant in the process. As I said before, Zepbound works for me because I’m not always hungry, and when I do sit down to eat a meal, I cannot physically eat as much as I used to be able to eat. That is still true. But if I want to get to my goal of being considered merely overweight, I’m going to need to lose at least another 25 pounds. That’s going to take a more conscious effort cut out even more snacks, late night treats, booze, etc.

Meanwhile, I finished listening to Johann Hari’s book Magic Pill, which is about these new drugs, and based on his research and own experiences on the meds— in his case, Ozempic. Hari is a Scottish writer/journalist whose fast-rising career in British media almost ended in 2011 when he was caught plagiarizing and fabricating huge elements of his stories. He made a comeback a few years later with a couple of books about addiction and depression, and also a couple of very well received Ted Talks.

I became familiar with Hari from his previous book, Stolen Focus: Why You Can’t Pay Attention. As the title suggests, it’s about the loss of attention and focus I think most of us sense in our day-to-day lives. Hari mostly blames cell phones and the intentionally addicting properties of social media, and also a host of other environmental and cultural factors. He presents the book as a literal journey: it starts with him traveling America with his nephew, and then Hari recounts his a solo trip to Provincetown, Massachusetts where he was on a social media detox and offline for several weeks. The rest of the book has him traveling the world, talking to various experts. All along the way and as a direct result of the previous plagiarism/fabrication scandals, he cites his work in detail, both in the notes in the book and on his website about the book.

For the most part, I agree with the arguments that Hari makes, though not everything— I think Hari goes too far with some of his claims about the dangers of social media and the causes of ADHD. But those disagreements were part of what made that book interesting. I assigned it in my first year composition and rhetoric classes last year, but that’s a different story. In short, Stolen Focus is a good and informative read. I’d recommend it.

Magic Pill is not.

Several reviews— notably this detailed take-down by Daniel Engber in The Atlantic— point out that in Magic Pill, Hari is slipping back into the sloppy journalism that got him in trouble before. He recycles many bits of past columns and books (I recognized a couple of these passages from Stolen Focus, complete with his nephew), and he significantly altered some of those stories to make them fit into this new book. He mixies up dates and places and people, and some of these errors are glaring. For example, Hari claims that a well-known British restaurant critic named Jay Rayner lost his love of food after being on Ozempic. Rayner posted on Twitter that that was “complete and utter bollocks.” The Telegraph did a deeper fact-checking dive into the book, and there are a lot of problems. In the end, as Marion Winik wrote in The Washington Post, Hari is constantly trying to create “ah-ha” moments out of things that anyone who has tried to lose weight— or merely eaten— already knows, like you eat less when you feel full.

Hari spends a lot of time mulling over the upsides of dramatic weight loss versus the downsides of yet still undetermined harms and the potential of needing to stay on these expensive medications for life. But in the closing chapter, I think he sums up what should be the decision making process for just about everyone with these medications in a couple sentences. To paraphrase: if you have a BMI higher than the low 30s (aka “obese”), you probably should consider trying these drugs. If you have a BMI lower than about 27 (which is the lower-end of “overweight”), you probably shouldn’t take these drugs.

What I did find interesting in listening to Magic Pill was his recounting of his experiences on Ozempic compared to mine on Zepbound. We’ve had similarly mild but persistent side-effects, and I too was surprised at how quickly it lowered my ability or desire to eat something like a Big Mac— though in his case, it’s fried chicken.

I also agree with the way Hari talks about BMI and when he gently critiques the concept of “health at every size.” Body Mass Index is far from an ideal system because of its lack of diversity and also its inability to distinguish between mass from muscles versus mass from fat, and because of its definition of “healthy” weight. I mean, for my height, BMI thinks I should weigh around 150 pounds, which is not a weight I’ve seen since middle school. At the same time, it’s kind of the best measure we’ve got. I of course agree that fat people should not be stigmatized or shamed or seen as failures because of their weight. But no one who is in the morbidly obese weight range should believe that there’s no correlation between weight and health, nor that the health problems of being too fat can be negated by only embracing body positivity.

But mostly, it’s about the differences. I began taking these drugs after years of being stuck at the same morbidly obese weight and because I did not want to develop type 2 diabetes and other health problems. Hari started taking Ozempic because he wanted to look better. As a side effect, I suppose, I’ve been pleased how Zepbound has also improved my appearance. Hari’s side effect was it improved his health.

Also, and I am surprised he never discusses this and it doesn’t come up in the reviews, Ozempic is a type 2 diabetes medication. Prescribing it “off-label” for weight loss has been common, but it also created shortages that made it a lot harder for people who actually need it for diabetes.

Hari describes a chaotic childhood where his Swiss father (who was also a chef at one point) angrily tried to force him to eat nutritious food and his mother and grandmother smuggled him junk food. He talks about how (before Ozempic, of course) he used to eat an entire bucket of Kentucky Fried Chicken by himself, how he used to go on these eating binges with a friend of his who was enormously fat and who died young several years before. Hari is in his early forties, and he says he has never cooked himself anything ever, and in one scene, he describes how a friend tried to teach him how to make some simple and healthy meals and how inept he was at it. And to hear him tell it, the food industry in the UK and the US are so hopelessly hell-bent on making all of us addicted to crappy food that he literally had to go to Japan to study how the richest nation with the lowest average BMI eats real food.

How much of this is exaggerated to fit the story is unclear, but as Engber wrote in that Atlantic piece, all of Hari’s “comeback” writings and books have been obsessed with “self-control and self-destruction,” which Hari argues has been brought about by his upbringing and other social factors. In other words, Hari blames this trauma, his eating disorders, and the complete lack of available health food choices for his weight. And by implication, Hari seems to think that this is how all fat people got that way.

I don’t think this is true for me. In my teens and early twenties, I was overweight. Most people in my extended family are overweight or more. But I think there were three things that really pushed me into that “morbidly obese” range: I quit smoking over 30 years ago (still the smartest thing I’ve done for my overall health, but I almost immediately gained 20 pounds); I did not take very good care of myself in graduate school; and I got older (it’s a whole lot harder to lose a few pounds in your 50s than it is in your 30s). What I’m saying is my weight gain has been slow and steady, and it wasn’t caused by trauma or an eating disorder. I think that’s how most people get fat.

Very much like Stolen Focus, Hari calls for larger societal changes to solve the problem— in this case, changes to the food industry and also in promoting (regulating?) healthier and more nutritious diets. I agree there are some things governments can do easily (calorie and ingredient information on packages and also at the fast food counter, taxes on sugary foods, etc.), and there are some things that governments might be able to do not so easily. There is a clear correspondence between obesity and income levels in the US, so doing more to get people out of poverty would help with that.

But here’s the thing: it’s not that hard to buy food from a grocery store or a restaurant that is healthy, and it is much easier to do this now than it was just a few years ago. Detroit (and other cities like it) definitely still have food desert neighborhoods, but they also have a lot of urban farming, mobile farmers markets, and, as development has come to parts of the city like midtown, so has Whole Foods and some other chains. And yes, it’s cheaper and easier to buy and prepare processed foods and junk food, but it’s not that much cheaper and easier than buying and preparing simple meals with vegetables, fish, and (less often) meat. We don’t have to go to Japan to eat like this and none of this is new information. As Michael Pollan discovered and advised us in 2008, it’s simple: eat food (by which he means not the overly processed things), not to much, mostly plants.

Here’s the other thing that Hari never talks about, nor does anyone else trying to convince us to eat healthier: besides the undeniable convenience of fast food and processed food, these manufactured and engineered and packaged “food” products are fucking delicious. I don’t know about you, but I don’t think I eat things that are bad for me just because I have “Daddy Issues” or depression or stress, or because there are few other options. I eat chocolate and doughnuts and ice cream and bacon and other clearly not good for me foods because they still give me pleasure.

The difference is with Zepbound, I just don’t eat that stuff as often.

New School Year Resolutions

So, kind of in the form of resolutions, here’s what I’m hoping to accomplish this school year— mostly with work stuff, with a few life things on the list too.

Wade Deeper into AI in My Teaching— Much Deeper

This fall, I’m going to be teaching two sections of the required first year writing course (aka “freshman comp”), and a junior/senior level course called “Digital Writing.”

For first year writing, I have never let students do research on whatever they wanted. Instead, I have always had a common research theme; for example, a few years ago, the theme was “social media,” meaning students’ semester-long research project had to have something to do with social media. This semester, the theme for my sections of first year writing is going to be “AI and your future career goals.”

The Digital Writing course is one I helped develop quite a while ago and it has gone through various evolutions. It’s a course that explores literacy as a technology, and it is also about the relationships between “words in a row” writing and multimedia writing. I have always started the course with readings from Walter Ong, Dennis Baron, a selection from Plato’s Phaedrus (where Socrates talks about the nature of writing), and similar kinds of texts, and also with an assignment where students have to “invent” a way of writing without any of the conventional tools. Maybe I’ll post more about that later here. In previous versions the course, the next two projects were something more multimedia-ish: podcast-like audio presentations, short videos, comics, memes, mashups, etc. But this semester, the second two projects are both going to be deep dives into AI— and I’m still trying to figure out what that means. In that class (and among other readings), I’m assigning Ethan Mollick’s Co-Intelligence: Living and Working with AI. I’m sure I’ll write more about all of that later too.

I don’t know how this is going to go, and I think it is quite possible that it will turn out poorly. I think it’ll be interesting though.

Try to be at least a little more “involved”

Being in my 36th year of teaching at the college level means that I’m getting closer to retiring— or at least officially retiring. I don’t think I can afford to retire for another seven years (when I’ll be 65), and I don’t think I’ll want to work much past 70 (12 years from now). Unofficially though, as the joke goes, I retired from service work six years ago.

Just service, mind you: I’m not “deadwood” because I’m still publishing and presenting (at least some), and I’m still trying to innovate with my teaching. But I’ve been unofficially retired from service and committee work in my department since about 2018, mainly because I spent 13 of my first 20 years here doing A LOT of service. I had a couple of different coordinator positions, I chaired a number of searches, and I had been on just about every elected committee at one time or another. I was burnt out, I wanted to get out of the way for younger faculty to step up, and I think my colleagues were tired of me being involved in everything. So for the last six years, I’ve been a lot more checked out. I meet with my fellow writing faculty about things, and I’ll go to a department meeting if there’s something important on the agenda, but that’s about it.

This year, I think I want to make more of an effort to be a little more involved with happenings on campus, I guess for two reasons. First, after six years away, I’m just ready to back, at least a bit. After all, I did a lot of service stuff for my first 20 years because I liked it and I was good at it. Second, EMU is going through some interestingly difficult times as an institution. Like most of the other regional universities in the state and a lot of similar places in the upper midwest and northeast, we’ve had falling enrollments for a while, and it seems to have gotten worse in the last two years. Falling enrollments have resulted in dramatic budget cuts and declining faculty and staff. At the same time, the administration tries to keep some money around the place with some dubious outsourcing decisions.

Just to add to the drama a bit: we’re going to have to have some serious conversations this year about the future of most of my department’s graduate programs; the dean has announced that she is taking an early buyout and is leaving at the end of the school year; and the president announced a while ago that he will be retiring at the end of his contract in 2026. Which, when I think about it, might be when the faculty union will be negotiating a new contract.

I could go on, but you get the idea. There’s too much going on around here now to be checked out.

I’m not quite sure what “trying to be at least a little more involved” means, and I’m not interested in taking on any huge service jobs. I’m not planning on running to be on the executive committee of the faculty union, for example. But I suppose it means at least going to more informational meetings about things on campus.

(I should note that I have already failed on this resolution: I attended a kicking off the semester department meeting this morning, but then decided to blow off the College of Arts and Sciences meeting in the afternoon).

Put together my next (maybe last?) sabbatical/research release project proposal

I have a few ideas, mostly about AI and teaching (not surprisingly). As was the case with my work on MOOCs and before that the emergence of different writing technologies and pedagogy, I’m interested to see what kinds of tools and technologies from the past were as disruptive in ways that are similar to AI. That’s kind of vague, both on purpose and because that’s where I’m at in the process.

Anyway, sabbaticals and semester long research releases are competitive, and I’m eligible to submit a proposal in January 2025 for a semester off from teaching to research in the 2025-26 school year.

Keep figuring out Substack

The look and feel of this interface versus WordPress is intriguing, and while there are features I wish this had, there’s something to be said for the simplicity and uniformity of Substack— at least I think so far. I don’t think I’ll be able to rely on revenue from newsletter subscriptions anytime soon, and that’s not really my goal. On the other hand, if could convince 1000 people to give me $100 a year for stuff I write here…

Keep losing weight with Zepbound

I started Zepbound in the first week of January 2024 and, as of today, I’ve lost about 35 pounds. It’s not all the result of the drugs, but it’s— well, yes, it is all the result of the drugs. Anyway, my resolution here is to keep doing what I’m doing and (ideally) lose another 25-30 pounds before the end of the semester.

Well, sort of….

The 2024-25 school year is my 36th teaching college (counting my time as a grad student and a part-timer), my 26th year as a tenure-track professor at EMU, and my 17th as a full professor. So it’s probably no wonder that when I think of the “new year,” I think of new school year at least as much as I think of January. On the old blog, I usually wrote a post around this time of year, reflecting on the school year that was and the year that was likely ahead of me. No reason to stop doing that now, right?

So, kind of in the form of resolutions, here’s what I’m hoping to accomplish this school year— mostly with work stuff, with a few life things on the list too.

Wade Deeper into AI in My Teaching— Much Deeper

This fall, I’m going to be teaching two sections of the required first year writing course (aka “freshman comp”), and a junior/senior level course called “Digital Writing.”

For first year writing, I have never let students do research on whatever they wanted. Instead, I have always had a common research theme; for example, a few years ago, the theme was “social media,” meaning students’ semester-long research project had to have something to do with social media. This semester, the theme for my sections of first year writing is going to be “AI and your future career goals.”

The Digital Writing course is one I helped develop quite a while ago and it has gone through various evolutions. It’s a course that explores literacy as a technology, and it is also about the relationships between “words in a row” writing and multimedia writing. I have always started the course with readings from Walter Ong, Dennis Baron, a selection from Plato’s Phaedrus (where Socrates talks about the nature of writing), and similar kinds of texts, and also with an assignment where students have to “invent” a way of writing without any of the conventional tools. Maybe I’ll post more about that later here. In previous versions the course, the next two projects were something more multimedia-ish: podcast-like audio presentations, short videos, comics, memes, mashups, etc. But this semester, the second two projects are both going to be deep dives into AI— and I’m still trying to figure out what that means. In that class (and among other readings), I’m assigning Ethan Mollick’s Co-Intelligence: Living and Working with AI. I’m sure I’ll write more about all of that later too.

I don’t know how this is going to go, and I think it is quite possible that it will turn out poorly. I think it’ll be interesting though.

Try to be at least a little more “involved”

Being in my 36th year of teaching at the college level means that I’m getting closer to retiring— or at least officially retiring. I don’t think I can afford to retire for another seven years (when I’ll be 65), and I don’t think I’ll want to work much past 70 (12 years from now). Unofficially though, as the joke goes, I retired from service work six years ago.

Just service, mind you: I’m not “deadwood” because I’m still publishing and presenting (at least some), and I’m still trying to innovate with my teaching. But I’ve been unofficially retired from service and committee work in my department since about 2018, mainly because I spent 13 of my first 20 years here doing A LOT of service. I had a couple of different coordinator positions, I chaired a number of searches, and I had been on just about every elected committee at one time or another. I was burnt out, I wanted to get out of the way for younger faculty to step up, and I think my colleagues were tired of me being involved in everything. So for the last six years, I’ve been a lot more checked out. I meet with my fellow writing faculty about things, and I’ll go to a department meeting if there’s something important on the agenda, but that’s about it.

This year, I think I want to make more of an effort to be a little more involved with happenings on campus, I guess for two reasons. First, after six years away, I’m just ready to back, at least a bit. After all, I did a lot of service stuff for my first 20 years because I liked it and I was good at it. Second, EMU is going through some interestingly difficult times as an institution. Like most of the other regional universities in the state and a lot of similar places in the upper midwest and northeast, we’ve had falling enrollments for a while, and it seems to have gotten worse in the last two years. Falling enrollments have resulted in dramatic budget cuts and declining faculty and staff. At the same time, the administration tries to keep some money around the place with some dubious outsourcing decisions.

Just to add to the drama a bit: we’re going to have to have some serious conversations this year about the future of most of my department’s graduate programs; the dean has announced that she is taking an early buyout and is leaving at the end of the school year; and the president announced a while ago that he will be retiring at the end of his contract in 2026. Which, when I think about it, might be when the faculty union will be negotiating a new contract.

I could go on, but you get the idea. There’s too much going on around here now to be checked out.

I’m not quite sure what “trying to be at least a little more involved” means, and I’m not interested in taking on any huge service jobs. I’m not planning on running to be on the executive committee of the faculty union, for example. But I suppose it means at least going to more informational meetings about things on campus.

(I should note that I have already failed on this resolution: I attended a kicking off the semester department meeting this morning, but then decided to blow off the College of Arts and Sciences meeting in the afternoon).

Put together my next (maybe last?) sabbatical/research release project proposal

I have a few ideas, mostly about AI and teaching (not surprisingly). As was the case with my work on MOOCs and before that the emergence of different writing technologies and pedagogy, I’m interested to see what kinds of tools and technologies from the past were as disruptive in ways that are similar to AI. That’s kind of vague, both on purpose and because that’s where I’m at in the process.

Anyway, sabbaticals and semester long research releases are competitive, and I’m eligible to submit a proposal in January 2025 for a semester off from teaching to research in the 2025-26 school year.

Keep figuring out Substack

The look and feel of this interface versus WordPress is intriguing, and while there are features I wish this had, there’s something to be said for the simplicity and uniformity of Substack— at least I think so far. I don’t think I’ll be able to rely on revenue from newsletter subscriptions anytime soon, and that’s not really my goal. On the other hand, if could convince 1000 people to give me $100 a year for stuff I write here…

Keep losing weight with Zepbound

I started Zepbound in the first week of January 2024 and, as of today, I’ve lost about 35 pounds. It’s not all the result of the drugs, but it’s— well, yes, it is all the result of the drugs. Anyway, my resolution here is to keep doing what I’m doing and (ideally) lose another 25-30 pounds before the end of the semester.

Oh-Oh-Oh, Oprah! (and Zepbound, Month 2)

Before I get to Oprah (and I intended that headline be sung to the tune of “Oh-oh-oh, Ozempic!”): my second month on Zepbound has been disappointing. In the first month, I lost a little over seven pounds on the “starter” dose of 2.5 mg weekly. Like all the other similar weight loss injectables on the market, the dose increases (with Zepbound, every month) until you reach the maximum dose (in this case 15 mg). So given that I lost about seven pounds with the lowest dose of this stuff, I assumed I’d continue to lose at about the same rate.

Well, not so much; instead, I stalled. My weight jumped around a bit so that at one point this past month, I was down another two pounds (for a total of nine), then I ended up gaining a pound or two, then losing again, etc. A month later, I’m where I was after month one. This is a bummer, especially since there are are lots of people in Reddit forums and the like posting about losing 20 pounds in the first month or two. Of course, besides the fact that the anonymous posts in discussion boards aren’t exactly peer reviewed, it seems like a lot of the people claiming these huge losses also have a lot more weight to lose.

But there is some good news. For one thing, I’ve got a long ways to go to get to the maximum dose– or whatever dose I land on as being the right dose. In the discussions, a lot of people talk about staying on a lower dose than longer, and that’s especially true for folks who have had a hard time with the side effects. Plus I’ve stalled but not bounced back up to where I started, which was what usually happens when I try to just “diet and exercise.” So I’m looking forward to see what happens when I ramp up from 5 mg to 7.5 mg.

Anyway, about Oprah:

As was reported in numerous sources the other day, O and Weight Watchers have decided to part ways. The New York Times (like this story) and similar outlets reported this was an “amicable” split. “‘Her decision was not the result of any disagreement with the company on any matter relating to the company’s operations, policies or practices,’ WeightWatchers said in the filing.” Also, she’s not profiting from selling her stock: “The company said in the statement that Ms. Winfrey would donate the value of her holdings in WeightWatchers to the National Museum of African American History and Culture in Washington in part to ‘eliminate any perceived conflict of interest around her taking weight loss medications.'” In other words, the story that both Oprah and Weight Watchers want to tell is this is just one of those things, we’re all happy about this, let’s let bygones be bygones, etc.

This could all very well be true. But it doesn’t take much picking at this to make me think this isn’t the whole story.

I have some personal experience with Weight Watchers, believe it or not. I can’t remember exactly when this was (maybe the late 2000s? the early 2010s?), but for about three or four years, I was a dues-paying member. I joined up with Annette, who, maybe 35 years ago and before we met, was on Weight Watchers and successfully reached her goal weight– which is to say it did work for her, at least at one point. The whole premise and purpose of Weight Watchers back then was quite straight-forward: eat less and maybe kinda/sorta exercise. The support meetings were mostly people talking about the challenges of dieting, along with celebrating the successes that some folks had, and perhaps a little shaming for the folks who weren’t as successful. For me, it didn’t work because success on Weight Watchers (at least back then) hinged on fastidiously keeping track of everything you ate with a system of points, and I’m just too lazy to do that. I’m pretty sure that when I stopped going to meetings, I was at the same weight as when I started.

Like I said, I don’t remember exactly when this was, but I do know it was before 2015. That’s when Oprah bought a 10% stake in what was already becoming a less profitable company. Her investment got her a seat on the board, and she became the primary public face/spokesperson for the company. That’s also when Weight Watchers started to rebrand itself as the more abstract WW. Instead of being all in on limiting calories, WW tried to pivot become a more “body positivity/acceptance” and healthy lifestyle kind of enterprise. They focused a lot more on exercise, a new line of WW cook books and new recipes (remember cauliflower crust pizza?) and food products, and more emphasis on apps for tracking food and online discussions, and a lot less emphasis on f2f meetings. For a while, this seemed to help the company. According to this May 2018 article in Money, Oprah’s $43.5 million investment ballooned quickly to more than $400 million. Sometime in 2018, she sold $110 million worth of her stock, and she also donated to her charitable foundation another $22.6 million from stock.

There’s nothing wrong with someone making a lot of money from what turned out to be a smart investment, so kudos to Oprah, at least back in 2018. But after reaching a high price mark of $101 a share in June 2018, the stock fell to $17.70 a share in April 2019. WW shares bounced up and down like a yo-yo dieter for a few years until falling even further by 2022. The day after Oprah announced she and WW were parting ways, the stock was $3.30 a share. In other words, that donation to eliminate any “perceived conflict of interest around her taking weight loss medications” is just a tax write-off.

Oprah has also significantly changed her story about weight loss medications. Back in September 2023, Oprah hosted a panel discussion for Oprah Daily (which is a subscription-based website of all things O) called “The Life You Want Class: The State of Weight.” It featured Oprah and a panel of experts on obesity and weight loss, and for the most part, the emphasis was on characterizing obesity as a disease, not about “willpower” per say, and also on body acceptance. But as People reported back then, when the discussion turned to Ozempic and similar drugs, Oprah was resistant:

“Shouldn’t we all just be more accepting of whatever body you choose to be in? That should be your choice,” Winfrey said during the panel. “Even when I first started hearing about the weight loss drugs, at the same time I was going through knee surgery, and I felt, ‘I’ve got to do this on my own.’ Because if I take the drug, that’s the easy way out.'”

In the same discussion, Oprah went on to explain that when she had surgery on both of her knees, she specifically decided against using any weight loss drugs, instead sticking to diet and a lot of hiking as exercise. It’s worth noting that as soon as Oprah said the drugs were the “easy way out,” the other panel members jumped in to emphasize that we need to think of obesity as a disease, it’s not about willpower, and so forth.

Still, the “mixed messages” from Oprah was problematic, particularly in terms of Weight Watchers’ (oops, I mean WW’s) efforts to get into the semaglutide and tirzepatide business themselves. As this little video snippet from Yahoo! finance makes clear, the only positive moment in Weight Watcher’s stock price in the previous year was the announcement that they were going to start offering these meds along with diet, exercise, and lifestyle. So for the company’s most famous stake holder, board member, spokesperson, and (for many WW customers) most inspirational persona to be skeptical of these new drugs was not the company line.

The other thing is Oprah was pretty explicit at this event that she had not herself taken Ozempic or similar drugs. As recent as early November, the “secret” to Oprah’s latest weight loss was being reported as being about following the WW diet and exercise. But by December, Oprah admitted she had been using these meds, but she still has not said what drug she’s been taking and when she started taking these drugs, and she describes the meds as weight “management” (rather than a weight loss) tool.

I have no doubt that Oprah did lose a lot of weight with the dieting and exercise she did after her knee surgeries a couple years ago. But I also have to think that she started whatever drug she’s on earlier than November– maybe even while she was claiming that taking a drug was the easy way out. In the stories back in December— when she first revealed she had been taking meds– she spoke about how she had “released the shame about it.” I suppose that means the shame of being overweight in the first place, but I also wonder if she was “releasing shame” about lying about being on these drugs.

I suppose Oprah had to bail on WW in part because of the story of her own weight gains and losses– an aspect of her celebrity image she’s cultivated for decades. After resisting them, Oprah seems to now recognize that these drugs do make a difference that simply cannot be matched by diet and exercise alone. That’s a pretty big shift from the story she’s been selling with WW as the weight loss plan where you can eat what you want and not being on a diet, including eating lots of bread.

But ultimately, business is business. Oprah cashed out of WW a long time ago, and at this stage, she’s leaving a sinking ship.

Zepbound, Month 1

A while  back, a Facebook “friend” (which is to say not so much a friend friend, but someone I know well enough from the academic world that I’ll talk with when I see him in person at a conference or something every few years) posted that he needed to lose 40 pounds and he was looking for suggestions. A lot of folks posted a lot of ideas, some of whom were also “friends” from academia who are very fit and athletic, competing in marathons and the like. All the advice boiled down to diet and exercise.

“Wait, in order to lose weight, I should eat less and exercise!?! Why, I never thought of that!” said every fat person in the world in their most sarcastic “this is just the way I talk” voice.

I wrote “Here’s what will be an unpopular suggestion: try drugs.” Which is what I’m currently doing.

Let me back up a bit:

I’m fat. I am not so fat that I need the seat belt expander on an airplane or I need to go to a special store to buy clothes, but I’m right on the edge of that level of fat. I should lose more than 40 pounds. To the extent that a Body Mass Index number matters, mine is in the high 30s. This puts me in the category of not just “obese” but on the edge of “morbidly obese.” It’s been like this for a long time.

I have of course tried many different diets and approaches, including Weight Watchers for a few years, but nothing has worked for long. For quite a while now, I’ve been completely locked into the same weight, plus or minus about 5 pounds: I’ll try something new and lose a bit, then plateau, and then gain it back. This has happened again and again and again.

So I gave up, and instead I try my best to be the healthiest fat person I can be. I go to the gym a few times a week, I try to eat mostly healthy foods (though I often fail), I stay on top of my various numbers with regular doctor visits, and I live with it. And for the most part, I’m at peace with that: I’ve been at least “overweight” since I was a kid so it’s not that big of a deal.

Still, I know I need to lose weight. After all, it is called morbid obesity.

About this time last year, I started hearing and reading things about Ozemspic, Wegovy, and similar drugs. The piece that peaked my interest most was Jia Tolentino’s New Yorker March 2023 article “Will the Ozemspic Era Change Howe We Thing About Being Fat and Being Thin?” Specifically, it was this paragraph:

The drugs mimic a hormone called glucagon-like peptide-1, which stimulates insulin production and suppresses the production of glucagon, which raises blood sugar. The body naturally releases GLP-1 after a meal, and the hormone travels to the brain, triggering the feeling of fullness. GLP-1 drugs effectively inject that sense of satiety, and also slow the rate at which food empties out of the stomach; patients generally report a freedom from cravings and an inability to overeat without becoming ill. “I’m convinced that this basically replaced a signal my body has been missing my whole life,” a commenter in a Reddit group for people using semaglutide wrote recently. “All I can say,” a member of an online group called Lose the Fat wrote, “is that it is no wonder that skinny people think heavy people have no willpower. Their brains actually do tell them to stop eating. I had no idea.”

This really really hit home for me. I remember talking about constantly feeling hungry in Weight Watcher meetings, but the only solution offered was willpower. For me, that works for a day or two, tops– thus my being stuck at my current weight for over a decade.

So when I went to see my doctor for a check-up and routine tests last spring, I said I’d like to give one of these Ozemspic-like drugs a try. Here I need to acknowledge the privilege and good luck I have in this situation. First, my doctor, who had never brought up weight loss in previous visits, said that she thought I’d be a good candidate for one of these drugs. When you look at the discussion forums about weight loss drugs, it’s easy to find someone talking about having a doctor who refused to prescribe anything. Second, I have very good health insurance through my employer that covers these drugs, with a $25 a month co-pay. There’s no way I’d pay out of pocket for this stuff because it costs around $1000 a month.

She put me on Saxenda, which is less effective than Wegovy and some of the other drugs out last year, but she said it was more available at pharmacies. Ozemspic was not an option because I’m not diabetic and she wasn’t willing to do that kind of off-label prescription– plus Ozemspic was (and I believe still is) in short supply. So after a couple of months of unfortunate events and delays (it’s a long story), I started Saxenda in late July. I was on it for about five weeks and I lost about six pounds– and then the supply dried up.

I went back to my doctor who was apologetic about the shortages, which are largely the result of the drug companies not being prepared for the enormous demand. She said that I must be disappointed, but actually, not really. Oh sure, I wish I could have continued on the meds because it was clearly working. I lost weight because I wasn’t hungry all the time, and thus I did not need to eat as much to feel full.

So for me, that experience on Saxenda was proof of concept. This shit might work for me– eventually, once the supply came back.

All through the fall and into December, I kept trying to find either Saxenda or Wegovy with no luck. Meanwhile in the fall/early winter, another one of these medications was approved by the FDA for weight loss, Zepbound. This one, which (IMO) has the best name, is similar to Eli Lilly’s diabetes drug Mounjaro, and the research I’ve seen so far suggests it’s the most effective weight loss drug like this on the market so far. On average, people on this stuff lose around 22% of their body weight within 16 months. Do the math on your weight– that’s a lot.  This perhaps explains why Zepbound is being projected to be the best selling prescription drug of all time.

Anyway, I happened to be in Costco in early January and I asked at the pharmacy if they had Wegovy or Zepbound in stock. I didn’t think they would (and they didn’t have Wegovy), but it turned out they were having no problems getting Zepbound. So I started it on January 7, and, without going into all of the details (maybe I’ll get into that in the future), so far, so good. I’m at the end of week 4 and I’ve lost about seven and a half pounds– not bad for about 30 days. I just do not feel hungry and I also don’t need to eat as much to feel full.  Plus I have now already secured another two months supply, which means I have enough to (hopefully) see some significant results.

One of the folks on that Facebook post I mentioned responded to my comment about “try drugs” by saying something like “Sure, but then you have to stay on those drugs the rest of your life.” First off, check back with me in a year or two on that. The likelihood of regaining weight is somewhat debatable, and there are maintenance levels of these drugs as well. Second, we’re just at the beginning of these medications. There are a dozen similar meds being developed, and that’s going to eventually bring down the costs and make them easier to take (potentially not as an injectable, for example). And third, the same is also true with the meds I take (along with zillions of other people, of course) for cholesterol and blood pressure– or meds for diabetes, which I am trying to avoid. The first thing my doctors told me before I started meds for blood pressure and cholesterol was “diet and exercise,” but they still prescribed drugs. And of course taking Zepbound might mean that I’ll eventually be able to get off of the other meds.

So we’ll see what happens.